Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial
新型嵌合体中国mRNA(RQ3013)SARS-CoV-2疫苗异源加强免疫的有效性、免疫原性和安全性:一项随机、双盲、活性对照试验
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2025.2502250
Liu, Xiao-Qiang; Qi, Yang-Yang; Huang, Tao; Huang, Li-Li; Zhao, Ming-Xuan; Wang, Zhong-Fang; Dai, Jun; Wang, Yan-Xia; Chen, Jing-Jing; Yang, Xiao-Yun; Fan, Hui-Lan; Yan, Xue-Mei; He, Jian-Chang; Zou, Yan-Xiang; Jiang, Zhi-Wei; Zhan, Zhi-Fei; Tao, Si-Wen; Dai, De-Fang; Shi, Feng; Zhang, Qiong-Na; Yang, Xiu-Liang; Li, Xiao-Zhong; Li, Wei; Lu, Jing; Zheng, Jiang-Bing; Zhang, Zhi-Hua; Chen, Gao-Xiang; Su, Hong; Gao, Wei-Min; Seidlein, Lorenz von; Wang, Xuan-Yi; Yuan, Lin; Lin, Jin-Zhong